Drug Approval | December 30, 2024
Cenexi's Fontenay manufacturing facility receives 10 observations in ANSM inspection
Cenexi is committed to working closely with the ANSM to address the observations
Cenexi is committed to working closely with the ANSM to address the observations
This facility is considered to be in a minimally acceptable state of compliance with regard to current GMP
The TGA approval marks a pivotal step in Rusan Pharma’s expansion into the Australian market
The FDA conducted a comprehensive Pre-Approval Inspection (PAI) and cGMP audit
The recognition from Malaysia's NPRA, a member of PIC/S, opens doors to new global business opportunities
The GMP certificate will allow the manufacturing site in Hervás, Cáceres to manufacture active ingredients for the pharmaceutical industry that is based on medicinal plants
The inspection conducted by EDQM at its Visakhapatnam facility
The sample seized by CDSCO is not manufactured by Torrent and is in fact non-genuine and spurious
This approval reflects company’s unwavering commitment that the quality assurance
USFDA concludes inspection of Dr. Reddy's Laboratories R&D centre in Bachupally with zero observation
Subscribe To Our Newsletter & Stay Updated
